Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-28

Clinical Trial Update: Avatrombopag Usage in NSAA [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update for avatrombopag in aplastic anemia with drug effect considerations; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avatrombopag (avatrombopag)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Aplastic Anemia, Drug Effect | Phase 2, Phase 3 | Status: UNKNOWN